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Spatially and temporally deﬁned lysosomal leakage
facilitates mitotic chromosome segregation
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Lysosomes are membrane-surrounded cytoplasmic organelles ﬁlled with a powerful cocktail
of hydrolases. Besides degrading cellular constituents inside the lysosomal lumen, lysosomal
hydrolases promote tissue remodeling when delivered to the extracellular space and cell
death when released to the cytosol. Here, we show that spatially and temporally controlled
lysosomal leakage contributes to the accurate chromosome segregation in normal mam-
malian cell division. One or more chromatin-proximal lysosomes leak in the majority of
prometaphases, after which active cathepsin B (CTSB) localizes to the metaphase chromatin
and cleaves a small subset of histone H3. Stabilization of lysosomal membranes or inhibition
of CTSB activity during mitotic entry results in a signiﬁcant increase in telomere-related
chromosome segregation defects, whereas cells and tissues lacking CTSB and cells expres-
sing CTSB-resistant histone H3 accumulate micronuclei and other nuclear defects. These
data suggest that lysosomal leakage and chromatin-associated CTSB contribute to proper
chromosome segregation and maintenance of genomic integrity.
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Late endosomes and lysosomes (hereafter referred to aslysosomes) are acidic, membrane-surrounded organellesthat function as primary “recycling stations” of eukaryotic
cells1–3. Inside the acidic lysosomal lumen, over 50 hydrolases
ensure the digestion of cellular macromolecules delivered to them
by endocytic, autophagic and phagocytic pathways to breakdown
products available for metabolic reutilization. In addition to their
degradative and recycling roles, lysosomes are emerging as
metabolic signaling hubs that adjust cellular metabolism
according to the availability of energy and macromolecules by
regulating the activities of several metabolic kinases (e.g.,
mTORC1 and AMPK) and transcription factors (e.g., TFEB,
TFE3, and STAT3) located on their surface4–8.
Besides their established function in the terminal degradation
inside the lysosomal lumen, lysosomal hydrolases, especially
proteases of cysteine cathepsin family, have been assigned several
extracellular functions, e.g., in bone resorption, tumor invasion,
and tumor angiogenesis. These processes involve tightly con-
trolled Ca2+-regulated lysosomal exocytosis and the release of
lysosomal contents to the extracellular space9, where cysteine
cathepsins cleave speciﬁc substrates, including components of the
extracellular matrix, other proteases, chemokines and E-
cadherin10–12. Furthermore, lysosomes with their capacity to
digest entire organelles and cells can be considered as ticking
suicide bombs. Lysosomal membrane permeabilization serves as a
trigger for an evolutionarily conserved lysosome-dependent cell
death program, which contributes to numerous physiological
processes (e.g., immune tolerance and mammary gland involu-
tion), as well as to degenerative, inﬂammatory and microbial
diseases and cancer therapy13–16. Whereas drugs with lysoso-
motropic detergent properties, viral entry proteins, and microbial
toxins form pores in the endolysosomal membranes17–19, the
mechanisms underlying lysosomal membrane permeabilization
induced by other lysosome disrupting stimuli are as yet equivocal.
Suggested second messengers include reactive oxygen species20,
free fatty acids21, and lipid metabolites22, while lysosomal-
associated membrane proteins LAMP1 and LAMP223, acid
sphingomyelinase24, dihydroceramide desaturase 125 and cho-
lesterol26 have a stabilizing effect on the lysosomal membrane.
Upon intracellular lysosomal leakage, lysosomal hydrolases enter
the cytosol, where cathepsins can initiate apoptotic or non-
apoptotic cell death pathways27,28. With respect to their extra-
lysosomal functions, it is important to note that in spite of their
acidic pH optimum around 4.5, most cysteine cathepsins retain
their activity in neutral pH for a short while, albeit with changed
enzyme kinetics and substrate speciﬁcity11,12.
In order to create new, functional cells to eventually replace
the dying ones, somatic cells progress through a tightly controlled
cell-division cycle, which can be divided into interphase, mitosis,
and cytokinesis29. During interphase, cells grow in size, replicate
their DNA and synthesize other macromolecules and organelles.
The ﬁve phases of mitosis are characterized by (i) the initial
chromatin condensation in prophase, (ii) nuclear membrane
disintegration and initiation of mitotic spindle formation in
prometaphase, (iii) alignment of chromosomes in the equator of
the cell in metaphase, (iv) separation of sister chromatids to
two daughter cells in anaphase, and (v) reformation of nuclear
envelopes in telophase. Finally, the daughter cells separate
from each other in cytokinesis. Mitosis must be carried out
accurately to avoid mistakes in chromosome segregation, which
can lead to chromosome rearrangements, loss of chromosome
fragments or alterations in chromosome copy number. Such
errors are likely to disrupt tissue homeostasis and lead to cell
death or contribute to accelerated genomic instability character-
istic of aging and cancer30,31. Accordingly, mitotic chromosome
segregation is tightly monitored by the mitotic checkpoint that
delays the irreversible chromosome segregation until the chro-
mosomes are correctly attached to the mitotic spindle, each sister
chromatid pair having stable attachments to both poles of the
mitotic spindle through their kinetochore complexes at the cen-
tromeric region. Even though the cell division cycle is a tightly
controlled, errors in chromosome segregation occur, especially in
cancer cells32. Chromosome segregation errors detectable in
anaphase, such as lagging chromosomes, chromatin bridges, and
acentric chromatin fragments, can be caused by incomplete
chromosome replication, telomere attrition, unresolved DNA
damage repair intermediates and intertwined sister chromatids
resulting from replication stress in the S phase of the cell division
cycle or incorrect kinetochore-microtubule attachments fre-
quently established during early mitosis30,33–36. Lagging chro-
mosomes and acentric chromatin fragments arising from
breaking chromatin bridges segregate either to the proper or
incorrect daughter cell. Due to their delayed segregation, they
often fail to incorporate into the newly formed nucleus and form
so-called micronuclei, whose reintegration into the genome cau-
ses chromosomal instability that in its most extreme cases can
lead to an extensive rearrangement of chromosomes37,38.
Due to the strong degradative potential of lysosomes, it has
been widely assumed that the maintenance of lysosomal mem-
brane integrity is a prerequisite for cell viability. The recently
developed highly sensitive galectin puncta assay, which can detect
even a minor lysosomal leakage, has, however, challenged this
dogma39. This assay takes advantage of the high afﬁnity binding
of galectins (e.g., galectin-3/LGALS3) to the β-galactoside-rich
glycocalyx that decorates the luminal side of lysosomal
membranes39,40. Upon lysosomal membrane permeabilization,
cytosolic galectins enter lysosomal lumen and bind β-galactoside
with high afﬁnity, thereby leaving a mark on leaky lysosomes that
can be visualized even several hours after the lysosomal mem-
brane has regained integrity39. This sensitive method has revealed
that cells can tolerate a certain degree of lysosomal leakage, which
has opened the intriguing possibility that akin to the lysosomal
exocytosis which delivers lysosomal hydrolases to the extra-
cellular space, controlled the intracellular release of lysosomal
enzymes may carry some, as yet unknown, physiological
functions41.
Here, we demonstrate that leakage of cathepsin B (CTSB)
protease from chromatin-proximal leaky lysosomes in prometa-
phase assists mitotic chromosome segregation in mammalian
cells and tissues. Thus, controlled intracellular release of lysoso-
mal CTSB, indeed, serves an essential physiological function
during mitosis.
Results
Leakage of chromatin-proximal lysosomes during mitosis.
Employing antibodies against LGALS3 and lysosomal-associated
membrane proteins 1 (LAMP1) or 2 (LAMP2), we have pre-
viously demonstrated that most of the MCF7 breast carcinoma
and U2OS osteosarcoma cells growing in optimal culture con-
ditions are, as expected, devoid of LGALS3-positive, leaky lyso-
somes39. While optimizing the staining procedure, we realized,
however, that >50% of metaphase cells had a few weakly
LGALS3-positive lysosomes in the close proximity of the con-
densed chromatin (Fig. 1a, b; Supplementary Fig. 1a). Super-
resolution structured illumination microscopy (SR-SIM) con-
ﬁrmed that the LGALS3-positive lysosomes were in contact with
metaphase chromatin (Fig. 1c). Notably, >80% of the leaky
lysosomes co-localized with telomeric repeat binding factor 1
(TERF1) (Fig. 1d and Supplementary Fig. 1b), which binds with
high afﬁnity to the duplex telomeric DNA sequences throughout
the cell cycle36. On the contrary, practically none of the leaky
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lysosomes were found in the proximity of kinetochores in the
centromeric regions of the mitotic chromosomes (Fig. 1d and
Supplementary Fig. 1b).
As discussed above, lysosomal leakage can trigger the intrinsic
apoptosis pathway via cysteine cathepsin-mediated cleavage of
various BCL2 family proteins42. Consistent with the high viability
of U2OS cells in the optimal culture conditions used here, mitotic
cells containing LGALS3-positive lysosomes were, however,
devoid of BAX activation (Supplementary Fig. 1c), a sensitive
marker for apoptosis43, and other signs of cell death. Lysophagy, a
targeted autophagy of lysosomes, has recently emerged as the
mechanism by which cells can remove damaged lysosomes44. In
line with a dramatic decline in the autophagic activity during
mitosis45, the majority of leaky mitotic lysosomes did not co-
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Fig. 1 Leakage of telomere-proximal lysosomes during mitosis in vitro. a Representative confocal images of an MCF7 cell in metaphase stained for
LGALS3, LAMP1 and DNA as indicated. Value, mean percentage of metaphases with chromatin-proximal leaky lysosomes ± SD, n= 3 independent
experiments with 129 metaphases analyzed. b Schematic presentation of a positioning of leaky lysosomes in metaphase. c Representative super-resolution
structured illumination microscopy image of a leaky, LGALS3-positive lysosome in a mitotic MCF7 cell from 1 experiment with 10 mitoses analyzed.
d Representative confocal images of U2OS cells stained for LGALS3, telomeres (anti-TERF1) or centromeres (anti-centromere antibody; ACA) and DNA.
Values, mean percentage of chromatin-proximal LGALS3 puncta co-localizing with TERF1 or centromeres ± SD, n= 3 independent experiments with 29
randomly chosen areas with 61 metaphases analyzed. White squares mark areas magniﬁed in lower left corners. e Representative confocal images of leaky
lysosomes in synchronized U2OS cells in indicated phases of cell cycle (n > 50 for each phase). See Supplementary Fig. 1e for the synchronization protocol.
f Quantiﬁcation of (e). Dot plots, mean ± SD, n= 3 independent experiments with≥ 10 cells analyzed for each phase in each sample. g Quantiﬁcation of
leaky lysosomes in synchronized MCF7 cells in indicated phases of cell cycle. Dot plots, mean ± SD of three independent experiments with ≥22 cells
analyzed for each phase in each sample. P-values were calculated by one-way ANOVA combined with Dunnett’s multiple comparisons. Arrows, chromatin-
proximal leaky lysosomes. Scale bars, white 10 µm; yellow 1 µm; light blue 0,5 µm. Source data for a, d, f, g are provided as Source Data ﬁles.
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localize with EGFP-LC3 positive autophagic membranes (Sup-
plementary Fig. 1d). Instead, the SR-SIM images suggest that they
may recover by fusing with LGALS3-negative healthy lysosomes
(Fig. 1c).
To deﬁne the stage of mitosis, in which lysosomes leak, we
synchronized U2OS and MCF7 cells in the late G2 phase of the
cell cycle by treating them with a CDK1 inhibitor (RO3306) for
16 h, released them from the G2 block and followed the fate of
LGALS3-positive lysosomes throughout the mitosis (Supplemen-
tary Fig. 1e). Percentage of cells with chromatin-proximal
LGALS3-positive lysosomes remained at low interphase level in
prophase, peaked in prometaphase and declined thereafter close
to interphase values in anaphase, when LGALS3-positive
lysosomes either moved to the cell periphery and distributed to
daughter cells or disappeared (Fig. 1e–g; Supplementary Fig. 1f, g
and Supplementary Movie 1). The mitosis-speciﬁc lysosomal
leakage was not limited to cultured cancer cells but was observed
also in non-transformed human HEK293 epithelial kidney cells
(Supplementary Fig. 1h), cryptal cells in healthy murine intestines
(Fig. 2a, b; Supplementary Fig. 2a), and tumor cells in MCF7
breast cancer xenografts in mice (Fig. 2c, d). Leaky lysosomes
were also frequently observed in random mitotic interstitial cells
in non-dividing murine tissues, such as kidney (Supplementary
Fig. 2b).
Together, these data reveal a non-lethal lysosomal leakage,
which occurs in the close proximity of telomeres shortly after the
transition from prophase to prometaphase, as a widespread
phenomenon not only in cultured mammalian cells but also in
healthy and cancerous tissues in vivo.
Inhibition of lysosomal leakage causes segregation errors.
Fenton reaction and lipid composition of lysosomal membranes
are among the few known regulators of lysosomal membrane
integrity13. Hydroxyl radicals and oxidized iron generated by
Fenton reaction can lead to lipid peroxidation and subsequent
destabilization of lysosomal membranes20, whereas excess cho-
lesterol and acid sphingomyelinase activity promote lysosomal
stability24,26,46. To enlighten the mechanisms controlling mitotic
lysosomal leakage, we treated cells with an iron chelator (defer-
iprone), a lipid peroxidation inhibitor (α-tocopherol), anti-
oxidants (trolox and buthionine sulfoximine), cholesterol, a
cholesterol biosynthesis inhibitor (simvastatin) or an activator of
lysosomal acid sphingomyelinase (recombinant heat shock pro-
tein 70; rHSP70)24, and quantiﬁed chromatin-proximal leaky
lysosomes in metaphase. Short-term loading of lysosomes with
cholesterol during mitotic entry reduced the chromatin-proximal
lysosomal leakage signiﬁcantly without affecting the lysosomal
cysteine cathepsin activity (Fig. 3a, b; Supplementary Fig. 3a–d).
The cholesterol-induced increase in lysosomal membrane stability
was associated with a signiﬁcant increase in erroneous chromo-
some segregation, mainly manifesting as anaphase bridges, i.e.
physical links between incompletely separated sister chromatids
or joined chromatids or chromosomes, in the subsequent ana-
phase (Fig. 3c, d; Supplementary Fig. 3c). Contrary to cholesterol,
the other tested treatments affected neither the lysosomal leakage
in metaphase nor the chromosome segregation in anaphase
(Fig. 3a–d; Supplementary Fig. 3e, f). These data suggest that the
mitotic chromatin-proximal leakage of lysosomes may promote
the accurate segregation of chromosomes.
How could lysosomal leakage be linked to chromosome
segregation? One possibility is that extra-lysosomal hydrolases
assist chromosome segregation by degrading key substrates on
the chromatin. Supporting this, CTSB itself as well as M6PR
(mannose-6 phosphate receptor) that is essential for the
lysosomal localization of CTSB and other lysosomal hydrolases1,
RAB29 that is responsible for recycling M6PR back to Golgi
apparatus47, and MZF1 (myeloid zinc ﬁnger 1) transcription
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Fig. 2 Leakage of chromatin-proximal lysosomes during mitosis in vivo. a Representative confocal images of chromatin-proximal leaky lysosomes in
murine intestinal crypts stained for LGALS3, mitotic chromatin (P-S10-H3) and DNA. b Quantiﬁcation of (a). Dot plots, mean ± SD, n= 3 mice with ≥324
mitotic and ≥356 interphase cells from 3 non-consecutive sections analyzed for each mouse. See Supplementary Fig. 2a for the co-localization of LGALS3
and LAMP1 in intestinal crypts. c Representative confocal images of chromatin-proximal leaky lysosomes in orthotopic MCF7 breast carcinoma xenografts
from Balb/c nude mice stained for LGALS3, LAMP1, and DNA. (d) Quantiﬁcation of (c). Dot plots, mean ± SD, n= 4 mice with ≥165 mitotic and ≥156
interphase cells from 3 non-consecutive sections analyzed for each mouse. Arrows, chromatin-proximal leaky lysosomes. P-values were calculated by
unpaired, two-tailed Students t-test. Scale bars, 10 µm. Source data for b, d are provided as Source Data ﬁles.
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Fig. 3 Inhibition of lysosomal leakage or activity during mitotic entry causes chromosome segregation errors. a Quantiﬁcation of metaphases with
chromatin-proximal leaky lysosomes in MCF7 cells treated as indicated for 2 h upon release from late G2 arrest. Bars, mean+ SD, n= 3 independent
experiments with ≥50 metaphases analyzed for each sample. b Representative confocal images of (a). Arrows, leaky lysosomes. Scale bars, 5 µm.
c Quantiﬁcation of chromosome segregation errors in MCF7 cells treated as in (a). Bars, mean+ SD, n= 3 independent experiments with ≥50 anaphases
analyzed for each sample. d Representative confocal images of (c). Arrowhead, anaphase bridge. Scale bars, 5 µm. e Quantiﬁcation of metaphases with
chromatin-proximal leaky lysosomes in U2OS cells treated as indicated for 1.5 h upon release from late G2 arrest. Bars, mean+ SD, n= 3 independent
experiments with >70 metaphases analyzed for each sample. f Quantiﬁcation of chromosome segregation errors in U2OS cells treated as indicated for 1.5 h
upon release from late G2 arrest. Bars, mean+ SD, n= 6 independent experiments with ≥50 anaphases analyzed for each sample. g Representative
confocal images of (f). Arrow, anaphase bridge. Scale bars, 5 µm. h Duration of mitosis in non-synchronized U2OS cells that entered mitosis 1–6 h after
indicated treatments. Dot plot, mean duration of mitosis ± SD, n= 3 independent experiments with ≥10 mitoses analyzed for each sample. i Scatter plot of
(h). The percentages of mitoses lasting >40min are indicated. j Representative bright-ﬁeld images of (h). The minutes indicate the time from the rounding
of the cell. Scale bar, 10 µm. P-values were calculated by one-way ANOVA combined with Dunnett’s multiple comparisons. Source data for a, c, e, f, h, i are
provided as Source Data ﬁles.
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factor that enhances CTSB and cathepsin L (CTSL) transcrip-
tion48, were among the 572 genes whose depletion resulted in
severe mitotic defects in a previously published, genome-wide,
image-based siRNA screen for mitosis regulators in HeLa cervix
carcinoma cells (http://www.mitocheck.org)49. To test the validity
of the published screen data, we treated cells with a direct
inhibitor of CTSB (Ca-074-Me) or an inhibitor of vacuolar
H+-ATPase (Concanamycin A; ConA)50, which inhibits lysoso-
mal acidiﬁcation and thereby the proteolytic activation of CTSB.
A short-term treatment of cells with these inhibitors during
mitotic entry had no effect on the leakiness of mitotic lysosomes
in metaphase (Fig. 3e, alignment of chromosomes in metaphase
or the formation of the mitotic spindle (Fig. 3g), but increased
signiﬁcantly the errors in chromosome segregation visible in
anaphase (Fig. 3f), and delayed the mitotic progression of a subset
of cells as measured from the detachment of a cell to the
reattachment of the two daughter cells (Fig. 3h–i; Supplementary
Movies 2–4). It should be noted that the time from nuclear
envelope breakdown to the start of anaphase was not affected by
ConA pretreatment (Supplementary Fig. 3g). These data are in
concordance with the above-discussed screen, and suggest that
CTSB is the lysosomal effector molecule that promotes the correct
segregation of chromosomes in mitosis.
CTSB depletion causes mitotic defects in vitro and in vivo. As
discussed above, errors in chromosome segregation during
mitosis can cause genomic instability and aneuploidy31,35. In
order to test whether the segregation errors observed following a
short-term inhibition of CTSB activity during a single mitosis
translated to additional nuclear abnormalities during prolonged
CTSB deﬁciency, we used genetic means to deplete U2OS cells for
CTSB. In addition to increases in mitotic cells with missegregated
chromosomes, CTSB depletion by three independent siRNAs for
3–4 days resulted in an up to 4.3-fold increase in micronuclei-
containing cells and an increase in cells in G2/M phase of the cell
cycle (Fig. 4a–d; Supplementary Fig. 4a–c; Supplementary
Movies 5a–c). Notably, the abundance of mitotic defects corre-
lated with the efﬁcacy of the tested siRNAs, and the enhanced
downregulation of CTSB expression obtained by a double trans-
fection resulted in a further increase in chromosome segregation
errors (Fig. 4a–d; Supplementary Fig. 4a). Severe signs of genomic
instability and aneuploidy, i.e. micronuclei and polynucleated
cells, accumulated also in two independent clones of CTSB deﬁ-
cient U2OS cells created by CRISPR/Cas9-based gene editing
(Fig. 4e, f; Supplementary Fig. 4d). In order to exclude the pos-
sibility that the observed mitotic problems were caused by cell
culture artefacts, we compared mitosis-rich tissues, intestinal
crypts and epidermis, from wild type mice expressing Ctsb in
these tissues with the same tissues from Ctsb−/− mice51. Even
though previous studies have not reported any speciﬁc pheno-
types in Ctsb−/− intestines or epidermis52, careful analyses of
their nuclear morphology revealed a signiﬁcant accumulation of
micronuclei in Ctsb−/− tissues (Fig. 4g, h). A similar nuclear
phenotype was observed in intestines and epidermis from mice
deﬁcient for both Ctsb and Ctsl (Fig. 4g, h). Akin to the normal
tissues, Ctsb−/− pancreatic neuroendocrine tumors had more
micronuclei than wild type tumors, whereas the deﬁciency of a
related cysteine cathepsin, Ctss, had no detectable impact on the
nuclear morphology (Supplementary Figure 4e). In the pancreatic
tumors, the effect of Ctsb deﬁciency was, however, not statistically
signiﬁcant, probably due to a signiﬁcantly decreased proliferation
and increased cell death in Ctsb−/− tumors as compared to wild
type and Ctss−/− tumors53. The severe mitotic defects observed in
cells and murine tissues upon pharmacological or genetic inhi-
bition of CTSB/Ctsb strongly support the notion that this
hydrolase is required for proper chromosome dynamics during
mitosis.
CTSB inhibition causes telomere-related segregation defects.
Erroneous kinetochore-microtubule attachments can be either
syntelic (both kinetochores attached to the microtubules ema-
nating from a single spindle pole), or merotelic (one kinetochore
attached to both spindle poles), the latter being the main cause of
lagging chromosomes in anaphase54. On the other hand, pro-
blems caused by under-replicated DNA, intertwined sister chro-
matids or entangled telomeres in the presence of normal
amphitelic kinetochore-microtubule attachments result in the
formation of chromatin bridges with two centromeres/kine-
tochores segregating to the opposite poles36,38. In order to
enlighten the role of CTSB in chromosome segregation, we
characterized the types of segregation errors caused by lysosomal
inhibitors by combining immunolabelling of kinetochores/cen-
tromeres with detection of telomeres by ﬂuorescence in situ
hybridization (FISH). In addition to the expected, low fraction of
lagging chromosomes and acentric chromosome fragments in
U2OS cells, the elevated levels of chromosome segregation errors
caused by ConA and Ca-074-Me were mainly dicentric bridges
with central telomeres and peripheral kinetochores/centromeres
(Fig. 5a–c; Supplementary Fig. 5a), and thus not a consequence of
erroneous kinetochore-microtubule attachments, but more likely
caused by entangled telomeres. Normal alignment of metaphase
chromosomes as well as unchanged kinetochore levels of total
and active Aurora B kinase, which is responsible for the correc-
tion of most erroneous kinetochore-microtubule attachments55,
further supported a kinetochore-unrelated mechanism (Supple-
mentary Fig. 5b). In line with this, the majority of the accumu-
lating segregation defects caused by the treatment of cells with
CTSB siRNA for 3 days were either dicentric chromatin bridges
with amphitelic kinetochore-microtubule attachments and central
telomeres or telomere-positive acentric fragments devoid of
centromeres/kinetochores (Fig. 5d). These data suggest that CTSB
assists in untangling fused telomeres to promote accurate chro-
mosome segregation.
Telomere dysfunction increases mitotic lysosomal leakage.
Based on the localization of leaky lysosomes in the close proxi-
mity of telomeres (Fig. 1d), appearance of leaky lysosomes in
prometaphase shortly after the nuclear membrane disintegrates
(Fig. 1e–g), and the abundance of telomere-related segregation
defects upon CTSB inhibition (Fig. 5c, d), we speculated that
entangled telomeres or factors associated with them could serve
as triggers for the lysosomal leakage. To test this hypothesis, we
depleted cells for telomeric repeat binding factor 2 (TERF2),
which is responsible for the formation of the telomere protecting
t-loop structure and whose depletion thereby induces an excessive
formation of telomere fusions36,56. TERF2 depletion caused a
signiﬁcant increase in both the percentage of (pro)metaphases
with chromatin-proximal, leaky lysosomes and the number of
chromatin-proximal, leaky lysosomes per (pro)metaphase already
48 h after the addition of the siRNA (Fig. 5e–i). These data
provide indirect support for the idea that entangled telomeres
may serve as a trigger for the lysosomal leakage upon nuclear
membrane disintegration in (pro)metaphase. Further studies are,
however, required to identify detailed molecular mechanisms
governing this process.
Active CTSB decorates metaphase chromatin. The data pre-
sented above suggest that CTSB leaks out of the lysosomal
compartment in prometaphase to assist chromosome segregation
later in mitosis. To deﬁne whether CTSB actually associates with
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the mitotic chromatin, we set up a proximity ligation assay (PLA)
employing antibodies against CTSB and Ser-10-phosphorylated
Histone H3 (P-S10-H3), a marker of mitotic chromatin.
Approximately 75% of vehicle-treated cells had an abundant
mitosis-speciﬁc PLA signal (Fig. 6a, b), which was practically
absent in CTSB deﬁcient cells (Supplementary Fig. 6a). Short
treatments with either ConA or Ca-074-Me upon mitotic entry,
which did not prevent the leakage of lysosomes in (pro)meta-
phase but increased chromosome segregation errors in anaphase
(Fig. 3e–g), reduced the percentage of PLA-positive cells sig-
niﬁcantly (Fig. 6a, b). Because ConA and Ca-074-Me inhibit the
binding of CTSB to its substrates by inhibiting the proteolytic
maturation of CTSB and by binding to the active site of CTSB57,
respectively, the lack of the PLA signal following these treatments
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suggests that CTSB has to be in its active, substrate-binding
form in order to associate with chromatin. The association of
active CTSB with metaphase chromatin was further reinforced
by the close proximity of CTSB and double-stranded DNA
(dsDNA) in all studied metaphase chromosome spreads from
control U2OS cells and its absence in similar chromosome
spreads from Ca-074-Me-treated cells (Supplementary Fig. 6b).
Accordingly, staining of the metaphase cells with a lysosomal
marker (AlexaFluor® 488-Dextran) and Magic Red, which
becomes ﬂuorescent upon CTSB-mediated cleavage, revealed
extra-lysosomal, chromatin-proximal CTSB activity in 80% of
normal metaphases (Fig. 6c, d). Furthermore, immunoblotting of
lysates of metaphase-enriched control cells for histone H3, a
previously identiﬁed substrate of CTSB and CTSL12,58, revealed a
minor histone H3 band with increased motility, which was absent
in similar lysates from cells treated with Ca-074-Me or ConA
upon mitotic entry (Fig. 6e). Together, these data strongly support
the idea that active CTSB associates with metaphase chromatin.
Histone H3 cleavage by CTSB promotes chromosome segre-
gation. To investigate whether the chromatin-associated cathepsin
a
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activity is essential for the proper chromosome segregation, we
expressed cystatin B (CSTB), a cytosolic cysteine cathepsin inhi-
bitor, in its native cytosolic form or fused to either histone H2B or
H3 in U2OS cells, and compared the number of segregation errors
in these cells with cells transfected with an empty vector or EGFP
fused to histones H2B or H3. All ectopic proteins were expressed
in comparable levels, and as expected, wild type CSTB localized to
the cytosol and effectively inhibited the cysteine cathepsin activity
in cell lysates, whereas both CSTB and EGFP fused to either one of
the histones co-localized with DNA (Fig. 7a, b; Supplementary
Fig. 7a). Indicative of local, chromatin-associated cathepsin inhi-
bitory activity of CSTB-histone H2B and CSTB-histone H3
fusion proteins, chromatin extracts from cells expressing them
inhibited the activity of recombinant CTSL (rCTSL) in vitro by
84% and 81%, respectively, as compared to the activity in
the presence of chromatin from cells expressing the corresponding
EGFP-histone fusion proteins (Fig. 7c). The expression of
H3-CSTB, but not that of wild type CSTB or H2B-CSTB, sig-
niﬁcantly increased the number of chromosome segregation errors
(Fig. 7d), suggesting that cysteine cathepsin-mediated cleavage
of histone H3 could promote accurate chromosome segregation.
In vitro cleavage assay of chromatin extracts from transfected cells
conﬁrmed that histone H3-EGFP was cleaved by both recombi-
nant CTSB (rCTSB) and rCTSL even at pH 7.0, whereas histone
H3-CSTB was protected from the cleavage (Fig. 7e). The estimated
molecular weight of the carboxy-terminal H3-EGFP cleavage
fragment was approximately 10 kDa smaller than the full-length
protein suggesting that the cleavage occurred at the site close
to the CTSB cleavage site at Tyr-100 (Y100) of Histone H3 that
was recently identiﬁed using systems-level N-terminome degra-
domics approach12. In line with this, ectopic expression of Y100
mutants (Y100A, Y100F and Y100E) in U2OS cells resulted in a
signiﬁcant increase in mitotic defects, including segregation errors
and micronuclei (Fig. 7f, g), and puriﬁed Y100A mutant reduced
its cleavage by rCTSB and rCTSL in vitro (Fig. 7h; Supplementary
Fig. 7b). Notably, expression of histone H3 with a previously
suggested CTSL cleavage site, Leu-2158, substituted with trypto-
phan (L21W) had no detectable effect on chromosome segregation
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(Fig. 7f). In line with the ability of rCTSL to cleave histone H3
at Tyr-100, treatment of U2OS cells with CTSL inhibitor upon
entry to mitosis increased the number of segregation errors
in anaphase signiﬁcantly, albeit to a slightly lesser extent
than inhibition of CTSB by Ca-074-Me or the combined inhibi-
tion of CTSB and CTSL (Fig. 3f; Supplementary Fig. 7c).
Thus, cysteine cathepsin-mediated cleavage of a subset of histone
H3 in (pro)metaphase emerges as a mechanism by which lyso-
somal leakage promotes accurate chromosome segregation,
whereas the role of other putative cathepsin substrates, as well as
the role of other lysosomal hydrolases in this process, remain to be
studied.
Discussion
The lysosomal lumen is ﬁlled with a potent mixture of hydrolytic
enzymes, whose leakage to the cytosol triggers caspase-dependent
apoptosis, caspase-independent apoptosis-like cell death or
necrosis depending on the extent of lysosomal damage and the
ability of cells to activate different cell death pathways22,28.
Taking advantage of a highly sensitive galectin puncta assay to
visualize leaky lysosomes, we show here, that a minor, non-lethal
permeabilization of lysosomal membrane occurs frequently in
cultured human cells and healthy murine tissues in prometa-
phase. Furthermore, we provide data indicating that CTSB leak-
ing out of prometaphase lysosomes and acting on (pro)metaphase
chromatin promotes faithful segregation of chromosomes in
anaphase. First, stabilization of lysosomal membranes by cho-
lesterol loading during mitotic entry results in an increase in
anaphase segregation errors establishing a link between the
lysosomal membrane permeabilization and accurate chromosome
segregation. Second, the role of extralysosomal CTSB as an
effector molecule involved in chromosome segregation is
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supported by the presence of active CTSB on metaphase chro-
matin, increase in segregation errors upon pharmacological CTSB
inhibition during mitotic entry and further accumulation of
multiple nuclear defects following prolonged inhibition of CTSB
by genetic means. Third, the accumulation of mitotic defects
upon expression of histone H3 either mutated at the veriﬁed
CTSB cleavage site or fused to a potent cysteine cathepsin inhi-
bitor reinforces the mitotic role of chromatin-associated CTSB
and introduces histone H3 as one of its substrates in (pro)
metaphase. Finally, the physiological relevance of mitotic lyso-
somal leakage and CTSB in chromosome segregation is supported
by the abundance of mitosis-speciﬁc and chromatin-proximal
leaky lysosomes in healthy murine tissues and the accumulation
of micronuclei in Ctsb deﬁcient tissues.
Most chromosome segregation errors originate from problems
encountered during DNA replication in the S phase of the cell
division cycle33,38. The signiﬁcant increase in chromosome seg-
regation errors observed upon short-term inhibition of either
lysosomal leakage or CTSB activity during mitotic entry, i.e. after
the cells have completed the replication of their DNA, argues
against a role for lysosomal leakage or extralysosomal CTSB in
DNA replication. Instead, we show that CTSB associates with
chromatin in (pro)metaphase, where it helps to solve segregation
problems brought about by CTSB-independent mechanisms prior
to mitosis, possibly during the preceding S phase. The char-
acterization of chromosome segregation errors in the absence of
CTSB activity revealed an increase in dicentric chromatin bridges
with central telomeres, with no effect on the abundance of
telomere-negative chromatin bridges or segregation defects
associated with erroneous kinetochore-microtubule attachments,
e.g., lagging chromosomes or chromatin bridges with syntelic or
merotelic attachments54. Also upon prolonged inhibition of CTSB
by RNAi, the increase in chromosome segregation errors was
limited to telomere-related problems, including telomere-positive
acentric fragments and dicentric chromatin bridges. Telomere-
positive acentric fragments are likely to be derived from broken
telomere-positive chromatin bridges and may explain the accu-
mulation of micronuclei observed in cells and tissues lacking
CTSB/Ctsb for a longer time. The chromosome segregation errors
brought about by CTSB inhibition being exclusively telomere-
related, it is interesting that further disturbance of telomere seg-
regation by depletion of TERF2, a shelterin complex protein that
protects telomere ends against fusion36,56, leads to a dramatic
increase in lysosomal leakage in (pro)metaphase. Together with
the data showing that the leaky lysosomes appear in close
proximity of telomeres, these data support a model where fused
telomeres get into the contact with perinuclear lysosomes upon
the disintegration of the nuclear envelope and trigger their
leakage by a yet unknown mechanism. Subsequently, CTSB
leaking out of the lysosomes co-localizes with the chromatin
where it may help to resolve telomere-related errors, such as end-
to-end fusions between sister chromatids. CTSB-mediated clea-
vage of a subset of histone-H3 appears to be a part of this process.
CTSB being a potent hydrolase possessing both endopeptidase
and exopeptidase activity even at neutral pH outside the lysoso-
mal lumen11,12, it is, however, likely to have additional substrates
in metaphase, whose identity and role in chromosome segrega-
tion remains to studied.
Errors in chromosome segregation are common in most can-
cers. Even though they can cause genomic instability and thereby
enable transforming cells to acquire essential cancer-promoting
capabilities, chromosome segregation errors as such are not
necessarily tumorigenic31. Instead, high rate of chromosome
missegregation is more likely to promote senescence and cell
death31,59,60. In line with this, Ctsb deﬁciency is not associated
with a tumor phenotype in mice. Instead, it delays tumor onset
and progression in various murine tumor models, i.e. MMTV-
PyMT breast cancer61, Rip1-Tag2 pancreatic neuroendocrine
tumors53, RasG12D/TP53−/− pancreatic ductal adenocarci-
noma62, and APCmin intestinal polyps63. The tumor suppressive
role of Ctsb deﬁciency is, however, not solely caused by the
mitotic problems described here as the frequently observed
increase in Ctsb/CTSB expression in murine and human tumors
stimulates tumor progression by numerous means, e.g., by
supporting the increased metabolic needs of cancer cells, pro-
moting cancer cell migration and invasion and stimulating
angiogenesis10,48. Furthermore, extracellular Ctsb/CTSB pro-
duced mainly by tumor-inﬁltrating macrophages enhances cancer
cell proliferation and metastasis in a paracrine fashion10. Thus,
the loss of potent tumor-promoting functions of Ctsb may
counteract the survival of a few potentially tumorigenic cells
arising as a result of chromosome segregation errors in Ctsb
deﬁcient mice. In agreement with this, Ctsb deﬁcient Rip1-Tag2
pancreatic neuroendocrine tumors have a signiﬁcant increase in
apoptotic cells53. Contrary to Ctsb deﬁciency, which counteracts
tumor growth by multiple mechanisms, other means to interfere
with the mitotic, chromatin-associated CTSB activity may favor
the survival of cells with genomic instability and thereby promote
tumorigenesis. In this context, it is interesting to note that several
epidemiological and experimental studies have suggested a
cancer-promoting role for cholesterol64, which effectively inhibits
lysosomal leakage in (pro)metaphase and increases chromosome
segregation errors in anaphase in vitro. It remains, however, to be
studied whether cholesterol accumulation in vivo is sufﬁcient to
stabilize lysosomes and induce chromosome segregation errors. It
will also be interesting to investigate whether mitotic lysosomal
leakage and the ability of CTSB to assist telomere segregation is
reduced by the aging-associated general decline in lysosomal
activity65. Such an association is indirectly supported by a recent
study reporting an age-related increase in chromosomes with
sister telomere loss or sister telomere chromatid fusions in per-
ipheral blood mononuclear cells throughout the human
lifespan66.
In conclusion, we have here identiﬁed spatially and temporally
deﬁned intracellular lysosomal leakage and subsequent CTSB-
mediated cleavage of a subset of histone H3 as frequent events
that contribute to the appropriate segregation of telomeres in
cultured human cells and healthy murine tissues. In addition to
the importance of mitotic lysosomal leakage in the maintenance
of genomic integrity, our data opens the possibility that con-
trolled release of lysosomal hydrolases may also regulate other
cellular processes.
Methods
Cell culture and treatments. U2OS human osteosarcoma (ATCC® HTB-96™) and
HEK293 human embryonic kidney (ATCC® CRL-1573™) cells were obtained from
American Type Culture Collection (ATCC). The cells were authenticated by ATCC
and used within 6 months after thawing. U2OS-mCherry/LGALS3 cells were
kindly provided by Dr. Harald Wodrich (Laboratoire de Microbiologie Fonda-
mentale et Pathogénicité, Bordeaux, France)67. U2OS-H2B–GFP cells68, the
S1 subclone of MCF7 human breast adenocarcinoma cells69 and MCF7-EGFP-LC3
cells70 originated from our laboratories. U2OS and MCF7 cells were authenticated
by chromosome spreads and RNASeq, respectively. Cells were grown in high-
glucose Dulbecco’s modiﬁed Eagle’s medium (DMEM, Thermo Fisher Scientiﬁc,
31966-021) supplemented with 10% fetal calf serum (FCS, Life Technologies,
10270-106) and penicillin/streptomycin (Life Technologies,15140-122). All cell
lines were regularly tested and found negative for mycoplasma using Venor®GeM
Classic PCR kit (Minerva Biolabs, 11-1100).
When indicated, cells were treated with indicated concentrations of α-
Tocopherol (Sigma-Aldrich, T3251), Buthionine-sulfoximine (Sigma-Aldrich,
B2515), Ca-074-Me (Merck Millipore, 205531), Cathepsin L inhibitor IV
(Calbiochem, 219433), cholesterol (Sigma-Aldrich, C3045), concanamycin A
(Santa Cruz Biotechnology, sc-202111), deferiprone (Sigma-Aldrich, 379409),
dimethyl sulphoxide (DMSO, VWR Life Science, AMREN 182), recombinant
Hsp70 (Ref. 24, kindly provided by Thomas Kirkegaard, Orphazyme A/S,
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Copenhagen, Denmark), RO3306 (Merck Millipore, 217721), trolox (Calbiochem,
648471) or simvastatin (Sigma-Aldrich, 38956).
Murine tissues. MCF7 tumor xenografts were collected from control mice during
a previous study39. Brieﬂy, MCF7 cells (10 × 106 cells in Geltrex (Life Technologies)
in 120 µl) were inoculated into an axillary mammary fat pad of 8–10 weeks old
female FOX CHASE severe combined immunodeﬁcient (SCID/FOX, Charles River
Laboratories) mice treated with 0.7 µg per mL estrone (Sigma-Aldrich, E9750) in
drinking water starting 5–7 days before tumor inoculation. When tumor diameter
reached 5–6 mm, animals were treated p.o. with 200 µl vehicle (0.5% methyl cel-
lulose with 15 cP viscosity (Sigma-Aldrich, M7140) in 0.9% NaCl solution). After
two days, mice were sacriﬁced, and tumors were placed in 10% formalin ﬁxative
until embedding in parafﬁn. The study was approved by Dyreførsøgstilsynet,
Denmark.
Formalin-ﬁxed and parafﬁn-embedded kidneys were from untreated C57Bl/6
mice (Charles River Laboratories) collected during a previous study71, and kindly
provided by Dr. Andreas Linkermann (Christian-Albrechts-University, Kiel,
Germany). The study was approved by Christian-Albrechts-University
Institutional Review Board.
Small intestines collected from 20 to 25 weeks old female FVB/N mice (Charles
River Laboratories), as well as jejunum and epidermis from 2 to 10 weeks old
male or female wild type C57Bl/6 or FVB/N mice, Ctsb−/− C57Bl/6 mice51 and
Ctsb−/−/Ctsl−/− FVB/N mice72 were placed in 10% formalin ﬁxative and
embedded in parafﬁn. The study was approved by the regional board Freiburg.
Pancreatic islet tumors from RIP1-Tag2, RIP1-Tag2-Ctsb−/− and RIP1-Tag2-
Ctss−/− C57Bl/6 mice53 were snap-frozen during previous studies approved by the
animal care and utilization committees at Memorial Sloan Kettering Cancer
Center, New York, NY.
As indicated above, all animal studies were approved by the local authorities
and carried out in accordance with the NIH guidelines and the Protection of
Animals Act.
CRISPR/Cas9-mediated gene editing. CTSB knockout U2OS cell lines were
generated by CRISPR/Cas9-mediated genome editing, using predesigned ready-to-
use Cas9 and guide RNA sequences that target CTSB exon 2 in U6gRNA-Cas9–2A-
GFP (Sigma-Aldrich, ID HS0000248520/1). Selection of transfected cells was based
on GFP expression, using ﬂow cytometry (FACSVerse™, BD Biosciences). CTSB
deletion in the selected clones was veriﬁed by immunoblotting and sequencing.
Transfections. CSTB coding region was ampliﬁed from CSTB cDNA clone
IRATp970G1013D (Source Bioscience) with CSTB primers (5’-cgccagggatc-
caccggtcgccaccatgatgtgcggggcgccctccgccacgcag-3’ and 5’-aaggaaaaaagcggccgctca-
gaaataggtcagctcatcatgcttggc-3’ (TAG Copenhagen A/S). PCR products, pBOS-H2B-
EGFP (ref. 73), pBOS-H3-EGFP (Ref. 74), and pcDNA3.1(+) (Life Technologies)
were digested with BamHI-HF® (R3136S) and NotI-HF® (R3189S) restriction
enzymes from New England Biolabs, and ligated to generate pBOS-H2B-CSTB,
pBOS-H3-CSTB and pcDNA3.1-CTSB expression plasmids. Site directed muta-
genesis of pBOS-H3-EGFP construct was performed using the QuikChange
Lightning Site-Directed Mutagenesis kit (Thermo Fisher Scientiﬁc, C10425)
according to manufacturer’s instructions using primers 5’-aaa-
gagccctaccaaggcggcctcacaagcctcc-3’ and 5’-ggaggcttgtgaggccgccttggtagggctcttt-3’
for Y100A mutation, 5’-caaagagccctaccaactcggcctcacaagcctcc-3’ and 5’-ggaggcttgt-
gaggccgagttggtagggctctttg-3’ for Y100E mutation, 5’-agagccctaccaagaaggcctca-
caagcc-3’ and 5’-ggcttgtgaggccttcttggtagggctct-3’ for Y100F mutation and 5’-
cagccttggtagcccactgcttgcgtggcg-3’ and 5’-cgccacgcaagcagtgggctaccaaggctg-3’ for
L21W mutation (TAG Copenhagen A/S). Mutations were veriﬁed by sequencing at
LGC Genomics GmbH. Transfections were performed in Opti-MEM® I medium
(Thermo Fisher Scientiﬁc, 31985070) using Lipofectamine LTX Plus reagent for
cDNA (Life Technologies, 15338-100) or in complete medium using RNAiMAX
Lipofectamine reagent (Life Technologies, 13778150) and 20 nM siRNA or 30–50
pM esiRNA (All Star non-targeting control siRNA from Qiagen (SI03650318),
CTSB siRNA#1 (5’-gcugaagcuuggaacuucuggacaa-3’) from Invitrogen and CTSB
siRNA#2 (SASI_Hs01_00108036), CTSB siRNA#3 (SASI_Hs01_00108037), EGFP
MISSION® esiRNA (EHUEGFP) and TERF2 MISSION® esiRNA (EHU042991)
from Sigma-Aldrich) according to the manufacturer’s instructions.
Cell synchronization. When indicated, cells were synchronized in late G2 phase of
the cell cycle by incubation with 9 µM RO3306 for 16 h, washed twice for 5 min in
pre-warmed (37 °C) culture medium and allowed to progress for 1–3 h into the
desired phase of mitosis in pre-warmed culture medium containing indicated
inhibitors at 37 °C.
Antibodies. Primary and secondary antibodies used are listed in Supplementary
Table 1.
Immunoblotting. Cell lysates and chromatin-bound protein extracts were sepa-
rated in 4–15% or 12% Mini-PROTEAN TGX Gels (BIO-RAD, 456-1086 and 456-
1043), transferred to nitrocellulose membrane (BIO-RAD, 170-4158) using Bio-
Rad Trans-Blot Turbo system (Bio-Rad), and stained with indicated primary
antibodies and matching secondary HRP-conjugated antibodies listed above.
Immunoreactivity was detected following incubation with Clarity Western ECL
reagents (Bio-Rad, 170-5061) with Luminescent Image Reader (Fujiﬁlm, LAS-
4000), and quantiﬁed by densitometry with Image Studio Lite software (LI-COR
Biosciences).
Immunocytochemistry. Cells were grown on glass coverslips, ﬁxed in 4% paraf-
ormaldehyde (PFA, Ampliqon, 43226.1000), permeabilized and blocked in Dul-
becco’s phosphate-buffered saline (DPBS, Thermo Fisher Scientiﬁc, 14190-094)
containing 5% goat serum (DAKO, X090), 1% bovine serum albumin (BSA,
Amresco, E531) and 0.3% Triton-X-100 (Sigma-Aldrich, T9284), and incubated
with the indicated primary and matching Alexa Fluor®-conjugated secondary
antibodies listed above. Nuclei were stained with 2.5 µg per mL Hoechst 33342
(Sigma-Aldrich, B2261) and coverslips were mounted with Prolong Gold Antifade
mounting medium (Life Technologies, P36930) prior to confocal microscopy or
super-resolution structured illumination microscopy (SR-SIM).
Proximity ligation assay (PLA). PLA with intact cells were performed after ﬁxing
in 4% PFA and permeabilization in Tris-buffered saline (TBS) containing 5% goat
serum, 1% BSA and 0.3% Triton-X-100 using antibodies against CTSB and P-Ser-
10-histone H3, DuoLink in situ PLA Probes and Detection Reagents (Sigma-
Aldrich, DUO92008, DUO92005, and DUO92001) according to the manufacturer’s
instructions. Nuclei were stained with 2.5 µg per mL Hoechst 33342 and actin ﬁbers
with Alexa Fluor® 488-conjugated phalloidin (Thermo Fisher Scientiﬁc, A12379)
prior to confocal microscopy. To obtain chromosome spreads, cells were syn-
chronized as described above and released in growth medium containing the
indicated drugs and 0.2 µg per mL karyoMAX®/colcemid™ (Thermo Fischer Sci-
entiﬁc, 15212-012) for 1 h. Trypsinized cells were then washed in DPBS, resus-
pended in 75 mM KCl and incubated at 20 °C for 15 min before dropwise addition
of 250 µL MeOH/Acetic acid (3:1) on vortex and centrifugation at 1200 × g for 5
min. After removal of the supernatant, 1 mL MeOH/Acetic acid (3:1) was added to
the pellet and the sample was incubated for 1 h at 20 °C before centrifugation at
1500 × g for 5 min. The obtained pellet was resuspended in 250 µL MeOH/Acetic
acid (3:1) and dropwise placed on Superfrost plus™ slides (Thermo Fischer Sci-
entiﬁc, J1800AMNT), air-dried and incubated at 4 °C for a minimum of 14 h before
the PLA assay.
Immunohistochemistry. Parafﬁn blocks were processed for immunohistochem-
istry using standard techniques. Intestine sections (4 µm) were deparafﬁnized in
xylene, boiled in 10 mM trisodium citrate buffer (pH 6.0), and stained with indi-
cated primary antibodies at 22 °C for 2 h, matching Alexa Fluor®-conjugated sec-
ondary antibodies at 22 °C for 1 h, and stained with 2.5 µg per mL Hoechst 33342
prior to confocal microscopy. Tumor xenograft and kidney sections (4 µm) were
further deparafﬁnized and rehydrated with descending alcohol series, boiled in
Tris-EDTA antigen retrieval buffer (pH 9.0) for 10 min, and blocked in 1% FCS in
TBS. Indicated primary antibodies in TBS containing 0,1% Triton-X and 1% BSA
were incubated for 16 h at 4 °C and appropriate Alexa Fluor®-conjugated sec-
ondary antibodies at 22 °C for 15–60 min with 1 µg per mL Hoechst prior to
confocal microscopy.
Immuno-ﬂuorescence in situ hybridization (ImmunoFISH). Cells ﬁxed, per-
meabilized and immunolabelled for indicated proteins were crosslinked with 4%
PFA in DPBS for 20 min and incubated with 1 mg per mL RNase (VWR Life
Science, 866) in DPBS for 20 min at 37 °C. Cells were then washed twice in DPBS,
dehydrated in 70%, 85%, and 100% EtOH and air-dried before the DNA was
denatured at 80 °C in hybridization buffer (10 mM NaHPO4 (pH 7.4), 10 mM
NaCl, 20 mM Tris (pH 7.5), 70% formamide and 1% maleic acid buffer (100 mM
Maleic acid, 150 mM NaCl, 175 mM NaOH, pH 7.2) with 100 mg per mL blocking
reagent (Sigma-Aldrich, 11096176001) containing 800 ng per mL TelC-Alexa488
PNA telomere probe (Panagene, F1004) for 4 min, and cells were incubated for 2 h
at 22 °C in a humid and dark chamber. After 10 min wash in DPBS with 0.1%
Tween-20 (65 °C) and 1 min wash in 2x SCC buffer (0.3 M NaCl, 30 mM sodium
citrate, pH 7.2) with 20% Tween-20, the cells were dehydrated in 70%, 85%, and
100% EtOH and air-dried before the DNA was stained with 2.5 µg per mL Hoechst
33342. The coverslips were mounted on glass slides using Prolong Gold Antifade
mounting medium before confocal microscopy.
Cholesterol staining. Cells were ﬁxed with 4% methanol-free PFA and incubated
with 50 µg per mL ﬁlipin III (Sigma-Aldrich, F4767) in DPBS at 37 °C for 30 min.
When indicated, cells were additionally stained for LAMP2 and analyzed as
described in “immunostaining” section above.
Confocal microscopy. Images were captured with a Zeiss LSM700 microscope
with Plan-Apochromat 63×/1.40 Oil DIC M27 objective and Zen 2010 software
(Carl Zeiss).
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SR-SIM. Thin (0.1 µm) z-stacks of high-resolution image frames were collected in
5 rotations by utilizing an alpha Plan-Apochromat 100×/1.46 oil DIC M27 ELYRA
objective and ELYRA PS.1 Microscope (Carl Zeiss) equipped with a 488 nm laser
(100 mW), 561 nm laser (100 mW) and iXon DU 885 EM-CCD camera (Andor
Technology). Images were reconstructed using ZEN software (black edition, 2012)
based on a structured illumination algorithm75. Analysis was performed on
reconstructed super-resolution images in ZEN. Maximum-intensity projections
were produced and 3-D rendering was performed of selected regions of interest,
using a render series of 150 frames.
Live-cell imaging. To visualize anaphase bridges, U2OS-H2B-GFP/mCherry-α-
tubulin cells were plated on 8-well chambered cover glass (Thermo Scientiﬁc,
155409) and imaged in subconﬂuent conditions. Cells were incubated in media
supplemented with 25 mM HEPES and treated as indicated immediately prior to
imaging. Cells were imaged throughout cell division with 2-min frame interval. To
follow lysosomal permeabilization during mitosis, U2OS-LGALS3-mCherry cells
were plated on 8-well chambered coverglass and loaded overnight with 0.5 mg per
mL 10 kDa dextran coupled to Alexa Fluor® 488 (Thermo Fisher Scientiﬁc,
D22910). Excess dextran was washed away and cells were allowed to settle to new
medium supplemented with 25 mM HEPES for a minimum of 2 h before imaging.
Cells in mitosis were imaged at 1 frame/minute and LGALS3-positive lysosomes in
dividing cells were followed until anaphase. All live-cell imaging was performed in
a heated chamber (37 °C) using a 60× NA 1.4.a objective mounted on a Perki-
nElmer spinning-disc confocal microscope.
U2OS-H2B-GFP cells cultured in 35 mm glass-bottomed dishes (14 mm, No.
1.5, MatTek Corporation) were transfected with 5 nM of siRNA for 72 h for the
single transfections, and two times during 96 h for the double transfections prior to
time-lapse imaging, which was performed in a heated chamber (37 °C) using a
Plan-Apochromat 63×/1.4NA (Carl Zeiss) with differential interference contrast oil
objective mounted on an inverted Zeiss Axio Observer Z1 microscope (Marianas
Imaging Workstation from Intelligent Imaging and Innovations Inc. (3i), Denver,
CO, USA), equipped with a CSU-X1 spinning-disk confocal head (Yokogawa
Corporation of America) and three laser lines (488 nm, 561 nm and 640 nm).
Images were detected using an iXon Ultra 888 EM-CCD camera (Andor
Technology). Eleven 1 μm-separated z-planes covering the entire volume of the
mitotic spindle were collected every 2 min. All displayed images represent
maximum-intensity projections of z-stacks. Image processing was performed in
ImageJ (Fiji)76.
Aurora B assay. U2OS cells were grown on glass coverslips and treated as indi-
cated, ﬁxed for 10 min at 37 °C with 4% PFA diluted in PHEM buffer (60 mM
PIPES, 25 mM HEPES, 10 mM EGTA, 4 mM MgSO4, pH 7.0) to stain for AURKB-
P-T32377 or in PTEM buffer (20 mM PIPES, 0.2% Triton-X, 10 mM EGTA, 1 mM
MgCl2, pH 6.8) to stain for total AURBK. Cells were stained with indicated primary
antibodies and matching Alexa Fluor®-coupled secondary antibodies listed above
and DNA was counterstained with 0.1 µg per mL DAPI (Sigma-Aldrich, D3571)
before the coverslips were mounted with Fluoromount-G™ solution (Sigma-
Aldrich, 00-4958-02) on glass slides. Images were acquired in the Zeiss AxioOb-
server Z1 wide-ﬁeld microscope (63x Plan-Apochromatic oil differential inter-
ference contrast objective lens, 1.4 NA) equipped with a CoolSNAP HQ2 CCD
camera (Photometrics) using the Metamorph software.
For the quantiﬁcation of ﬂuorescence intensities at kinetochores, a MATLAB-
based algorithm was used .pngt from António Pereira, Instituto de Investigação e
Inovação em Saúde, Porto, Portugal). Fluorescence was measured by quantiﬁcation
of pixel gray levels on the different z planes within a region of interest
(kinetochore). Co-staining with anti-centromere antibody (ACA) was used to
deﬁne the kinetochore regions, which were then used to quantify the ﬂuorescence
intensity of the protein of interest in the same region. Background ﬂuorescence was
measured outside the region of interest and subtracted. Fluorescence intensities of
the protein of interest were normalized against centromere signals. Over 1000
kinetochores from 20–40 cells from two independent experiments were analyzed
for each protein.
In vitro histone cleavage assay. Chromatin was extracted using the Subcellular
Protein Fractionation Kit for Culture Cells (Thermo Fisher Scientiﬁc, 78840)
according to the manufactures instructions with the exception that the provided
protease inhibitors were substituted with 0.5 mM pefablock (Sigma-Aldrich,
11429868001). Equal amounts of chromatin (30 µg protein) were incubated at 37 °
C for 15 min in a pH-modiﬁed cathepsin reaction buffer (50 mM sodium acetate, 4
mM EDTA, pH 7.0), containing 0.5 mM pefabloc, 5 mM dithiothreitol (Sigma-
Aldrich, D9779), and indicated amounts of rCTSB (Biovison, 7580), rCTSL (Bio-
vison, 1135) and ALLN (Calbiochem, 208719). Samples were subsequently boiled
for 5 min and analyzed by immunoblotting.
Cysteine cathepsin activity assays. To estimate the total cellular cysteine
cathepsin activity in cell lysates, cells were lysed using caspase lysis buffer (25 mM
HEPES, 5 mM MgCl2, 1 mM EGTA, 0.5 mM pefablock, 0.1 mM dithiothreitol and
0.025% Triton X buffer; pH 6.0) for 15 min on a shaking table at 4 °C. Cells were
then centrifuged for 5 min at 3000 rcf at 4 °C, and 50 µL supernatant was
transferred to a black bottom 96-well plate together with 50 µL substrate buffer
(Cathepsin reaction buffer at pH= 6, 8 mM dithiothreitol, 0.5 mM pefablock and
20 mM zFR-AFC (Sigma-Aldrich, P4157)). Lastly, light emission (excitation at 400
nm; emission at 489 nm) was measured on a Varioskan Flash spectral scanning
multimode reader (Thermo Fisher Scientiﬁc) every 55 s for 20 min at 37 °C. Values
were normalized by protein content.
To visualize the cysteine cathepsin acitivity in living cells, U2OS cells were
incubated with 0.25 mg per mL 10 kDa dextran coupled to Alexa Fluor® 488 for 16
h, washed and chased for 2 h. Magic Red Cathepsin B substrate (AbD Serotec,
ICT937) was added at 1:25 (vol:vol) with indicated treatments and cells were
incubated for 15 min at 37 °C before live cell imaging in a heated chamber (37 °C)
using a ×60 NA 1.4.a objective mounted on a PerkinElmer spinning-disc confocal
microscope. Confocal step size, 400 nM. Extralysosomal CTSB activity at mitotic
chromatin was deﬁned as the presence of Magic Red signal outside dextran-positive
lysosomes proximal to chromosomes.
Two-dimensional ﬂow cytometry. Cell cycle distribution was analyzed using the
Click-it EdU Alexa Fluor Flow Cytometry Kit (Thermo Fisher Scientiﬁc, C10425)
according to the manufacturer’s instructions. Brieﬂy, S-phase DNA was stained
with 1 µM EdU for 1 h and total DNA with FxCycle™ Far Red, both from the kit.
Cells were subjected to ﬂow cytometry (FACSVerse™, BD Biosciences) and ana-
lyzed with FlowJo version 10 software (FlowJo, LLC) for cell cycle distribution. The
percentages of cells in G1, S and G2/M phases were calculated with FlowJo by
gating the populations in a typical horseshoe-shaped dot plot.
Quantiﬁcation and statistical analyses. All experiments were performed a
minimum of three times and results are expressed as mean+ SD from ≥3 inde-
pendent experiments. For all image-based analyses ≥10 randomly chosen cells/
sample were analyzed. Multiple comparisons were carried out using one-way
ANOVA combined with Dunnett’s multiple comparisons test and comparisons of
two groups with unpaired, two-tailed Student’s t-test. Statistical analyses and
graphs were performed using Prism version 7.0a software (GraphPad).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All relevant data generated or analyzed during this study are included in this published
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